Stonepine Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.52M | Sell |
38,597
-9,403
| -20% | -$614K | 2.47% | 13 |
|
|
2025
Q1 | $13.6M | Buy |
48,000
+27,600
| +135% | +$7.85M | 13.28% | 1 |
|
|
2024
Q4 | $1.13M | Buy |
+20,400
| New | +$1.13M | 0.91% | 28 |
|
|
2022
Q3 | – | Sell |
-28,800
| Closed | -$854K | – | 20 |
|
|
2022
Q2 | $854K | Buy |
28,800
+2,740
| +11% | +$81.2K | 0.4% | 23 |
|
|
2022
Q1 | $733K | Sell |
26,060
-26,230
| -50% | -$738K | 0.3% | 26 |
|
|
2021
Q4 | $2.41M | Buy |
+52,290
| New | +$2.41M | 1.11% | 19 |
|
|
2016
Q2 | – | Sell |
-1,650
| Closed | -$56K | – | 24 |
|
|
2016
Q1 | $56K | Buy |
+1,650
| New | +$56K | 0.07% | 17 |
|